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Abstract
Backgrounds: Patients with rheumatoid arthritis (RA) have increased risk of sudden cardiac death (SCD), which is
two-fold higher than general population. The driving cause of SCD was considered due to lift-threatening
arrhythmia where systemic inflammation acts as the pathophysiological basis linking RA to autonomicdysfunction.
Methods: To assess the sympathetic over-activity of “inflammatory reflex”, we measured heart rate variability (HRV)
in a rat collagen-induced arthritis (CIA) model, whose arthritis is induced in Lewis rats by intradermal injection of
emulsion of type II collagen. Single-lead electrocardiogram (ECG) was recorded for 30 min every two days. Time
and frequency-domain parameters, detrended fluctuation analysis (DFA), deceleration (DC) and acceleration
capacity (AC) were analyzed.
Results: Compared with 9 control rats, many of HRV parameters of 9 CIA rats revealed significant different. At the
beginning of arthritis, LF/HF was significant higher than controls (1st week: 2.41 ± 0.7 vs. 1.76 ± 0.6, p < 0.05; 2nd
week: 2.24 ± 0.5 vs. 1.58 ± 0.5, p < 0.05) indicating intensive inflammatory reflex at the initial phase of inflammation but
no significant difference was observed in the following recover phase. The similar trend of DFA parameters was noted.
However, the DC appeared progressive lower despite of no significant increase of the LF/HF compared with controls
since 4th week.
Conclusions: We observed sympathetic over-activation of inflammatory reflex during early stage of arthritis in CIA rats.
The ongoing decline of DC indicated advanced cardiac autonomic dysfunction regardless of remission of acute arthritis.
Keywords: Autonomic function, Collagen-induced arthritis, Rheumatoid arthritis, Heart rate variability, Deceleration
capacity
Background
Rheumatoid arthritis (RA) is a common autoimmune
disease that is associated with progressive disability, sys-
temic complications, early cardiac death and socioeco-
nomic costs. RA is characterized by loss of tolerance to
self-proteins that contain a citrulline residue, where anti-
citrulline response can be initiated with T-cell, B-cell and
tumor necrosis factor α (TNF-α). Synovitis is launched
and perpetuated by positive feedback loops and in turn
promotes systemic disorders, including myocardial infarc-
tion, stroke and heart failure [1]. The cardiac mortality is
1.5-fold higher and sudden cardiac death (SCD) is twice as
likely among RA patients than general population. Al-
though the main focus of clinical setting is on accelerated
atherosclerosis and myocardial injury, chronic systemic in-
flammation may increase arrhythmogenicity via other
mechanisms and contribute to higher risk of SCD [2].
Synovitis derived inflammatory cytokines (interleukin-1,
interleukin-6 and TNF-α) could induce non-structural
myocardium change via direct electrophysiological effect
on cardiomyocyte and sympathetic overactivation [3].
Many studies demonstrated inflammatory cytokines could
prolong action potential duration via changing expression
and function of potassium and calcium channel [4–6].
On the other hand, signs of autonomic dysfunction in
RA population have been documented decades ago
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and involved cardiovascular nervous system [7]. Heart
rate variability (HRV) is a non-invasive, practical and
reproducible method to assess the effect of sympatho-
vagal balance on the heart. In general population, re-
duced HRV indicates increased sympathetic tone and
decreased parasympathetic system being associated with
higher risk of cardiovascular events [8]. Several studies in-
vestigating HRV in RA patients, reported a depression of
time- and/or frequency-domain measures of HRV, imply-
ing an increase in the sympathetic drive of the heart rate
in this population. We intend to test the hypothesis that
“inflammatory reflex” could be a mechanism leading to
heart impairment in RA [9].
Methods
Collagen-induced arthritis (CIA) in rat is an animal model
for rheumatoid arthritis (RA) and can be induced in Lewis
rat. The CIA model can be used to unravel mechanisms
involved in the development of arthritis and frequently
used to study the effect of new therapeutics.
Animals
Eighteen adult Lewis rats weighing 160–180 g were used.
The animals were housed under special pathogen-free
conditions at the animal facility. These rats were divided
into 2 groups: CIA and control group equally. The healthy
condition and physical activity of the rats were monitored
daily, and the body weight and paw thickness were mea-
sured and recorded every week.
Induction of arthritis
Chick Type II collagen (CII) (Chondrex cat. #20012) was
dissolved in 0.05 M acetic acid by gently stirring over-
night at 4 °C. Equal amount collagen and complete
Freud’s Adjuvant (CFA) (Chondrex cat. #7024) were
mixed in an ice-water bath, adding the collagen drop-wise
to the CFA while mixing. The same procedure was con-
ducted when mixing Bovine Type II collagen (Chondrex
cat. #20022) with Incomplete Freud;s Adjuvant (IFA)
(Chondrex cat.#7002) On day 0, 0.5 ml of the emulsion
(containing 0.5 mg Chick CII + CFA) was injected at the
base of the tail of each rat. On day 7, a second injection
(0.5 mg Bovine CII + IFA) was administered in the same
way. For arthritis assessment, all rats were monitored
three times a week by the same person blinded to the
treatment group, and the clinical scores were evaluated.
Zero score represents no edema or swelling in the joint; 1
score represents slight edema and erythema limited to the
foot and/or ankle; 2 scores represent edema and erythema
toes and most joints of the ankles; 3 scores represent se-
vere edema and erythema paw below ankle joint; 4 scores
represent edema and erythema of all paws including ankle
joint [10]. The cumulative score for all four paws of each
rat (maximum possible score of 16) was used to represent
the overall disease severity and progression. The model of
arthritis was considered successful when the scores were
greater than 5.
NN Interval recordings
The ECG of CIA rats was recorded for 30 min every two
days (CIA rats and controls). Prior to ECG recordings,
animals were conditioned for 7 consecutive days, 30 min
in each morning (0700–0900 h) on a self-made platform
(Additional file 1: Figure S1). The self-made platform
was designed to prevent rats to strip off recording elec-
trodes in non-anesthetized condition. A day before ECG
was firstly recorded, the ventral thoracic region of each
animal was carefully shaved. We placed the negative elec-
trode near the right shoulder and the positive electrode to
the left of the xyphoid space to obtain robust P, R, S, and
T waves, as human lead II configuration. We kept the rat
awaken and recorded ECG signal using a bioamplifier.
The ECG signal was analyzed using custom-made Lab-
VIEW software which automatically detected the R-waves.
The QRS complexes were automatically and manually
classified as normal sinus rhythm, atrial and ventricular
premature beats. The term “NN interval”, or the so-called
normal-to-normal intervals isthe intervals between adja-
cent QRS complexes resulting from sinus node depolar-
izations. ECGs were bandpass filtered (2–300 Hz) and,
after R wave peak detection, 180-s tachograms were
generated. The RR intervals were deduced from adja-
cent normal sinus beats and transferred to a personal
computer to be post-processed by a Matlab program
(Kubios HRV) [11].
Time and frequency domain parameters
The mean heart rate, standard deviation of N-N intervals
(SDNN) and root mean square of successive differences of
N-N interval (RMSSD) were used as time-domain mea-
sures of HRV. The power spectrum densities were esti-
mated by Welch’s averaged periodogram method [12].
The LF power (0.04 to 0.15 Hz) and HF power (0.15
to 0.4 Hz) were derived from the sum of area within spe-
cific frequency range under the power spectrum density
curve of the entire 30-min segment. The normalized
unit (NU) of HF (HF NU) or LF (LF NU) was calculated
as the ratio of the absolute powers of HF or LF to TP
and multiplied by 100.
Generally, SDNN reflects overall heart rate fluctuation.
RMSSD could represent parasympathetic tone and also
be sensitive to uneven beat detection. In terms of fre-
quency domain, LF is considered to reflect the combined
modulation of efferent vagal and efferent sympathetic
nervous system activity and HF is related to modulation
of efferent vagal activity by ventilation. LF/HF ratio is
often claimed to characterize “sympathovagal balance”
or “relative sympathetic activity” because the LF reflects
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modulation by both the sympathetic and parasympa-
thetic arms of the autonomic nervous system and the
HF band reflects parasympathetic activity [13].
Detrended fluctuation analysis
Detrended fluctuation analysis (DFA) quantified the cor-
relation properties of fractal-like dynamics caused by
complex interplay between vagal and sympathetic heart
rate regulation [14]. The DFA technique was used to
quantify the fractal scaling properties of short- and
intermediate-term R-R interval time series. Clinically, re-
duced DFA might be more precise in predicting fatal
arrhythmic events than that based on traditional methods
[15]. In this study, both the short-term (DFAα1, 4 to 11
beats) and long-term (DFAα2, >11 beats) scaling expo-
nents were calculated. All the analyses were performed by
using software developed in-house provided by Matlab 7.8
(Mathworks, Inc., Natrick, Ma, USA).
Deceleration and acceleration capacity
We used phase-rectified signal averaging method (PRSA)
to process sequences of R-R interval obtained from our
30-min recordings [16]. The PRSA software was bench-
marked against the freely available download from the
Technical University of Munich. Deceleration capacity
(DC) quantified spontaneous increases in NN intervals
and acceleration capacity (AC) quantified spontaneous
decrease in NN intervals. PRSA method could extract
periodicities from complex time series, including noise,
artefact, non-stationarities as well as periodic component.
Non-periodic components were eliminated thereafter.
Consequently, the PRSA computation is relatively robust
against artefact and ectopic beats with extensive editing of
ECG recording [17]. DC quantifies the increases in NN in-
tervals by the phase-rectified signal averaging method,
reflecting the capability to slow heart rate and AC charac-
terized the ability to speed heart rate [16].
Statistical analyses
The data were expressed as mean ± standard deviation.
A two-way, repeated-measures analysis of variance
(ANOVA) was used to evaluate statistical differences be-
tween groups (control versus CIA group) and among
follow-up durations (from 1st to 6th week). A p < 0.05
was considered statistically significant and the alpha
level was adjusted during multiple comparisons so as to
maintain the rate of Type I error at 5% during Holm-
Bonferroni post hoc analysis. When differences were
found in main effect, an independent-samples t test was
used to analyze differences between two groups at each
measurement time. All analyses were performed with
SPSS 19.0 (SPSS Inc. Chicago, IL).
Results
The rats in control group were healthy and without in-
flammation in joints (Fig. 1a) while the rats treated with
collagen were unhealthy and had progressive swelling
and redness appearance in the paws (Fig. 1b). The swell-
ing of joints in the CIA rats, especially hind paws, was
gradually aggravated and approached the peak in the day
18 (Fig. 1c and d). After that, the swelling was alleviated
gradually but the joints became stiff and the movements
of the limbs were limited.
The HRV parameters are shown in Table 1. The two-
way repeated measure ANOVA was conducted to find
out the difference HRV between groups and measure-
ment times. It showed a significant difference among
follow-up duration (p < 0.001), and between two groups
(p < 0.001). Significant interaction between the groups
and measurement times was shown (p < 0.05). In terms
of liner HRV, heart rate (458 ± 35 vs. 386 ± 25, p = 0.002)
and SDNN (8.23 ± 1.6 vs. 4.53 ± 2.5 ms, p = 0.004) of
CIA rats were significant higher than control group in
the first week. These changes persisted till 4th week (2nd
week, heart rate: 438 ± 31 vs. 411 ± 57, p = 0.02; SDNN:
12.28 ± 4.3 vs. 6.08 ± 3.4 ms, p = 0.002 and 3rd week,
heart rate: 471 ± 32 vs. 411 ± 6, p = 0.003; SDNN: 5.82 ±
2.7 vs. 3.9 ± 0.9 ms, p = 0.03) when the inflammation of
joins in CIA rats was relieved clinically. In frequency-
domain parameters, LF (1st week: 69.48 ± 5.7 vs. 61.71 ±
9.3, p = 0.03; 2nd week: 68.41 ± 5.1 vs. 60.00 ± 7.2, p = 0.02
and 3rd week: 68.78 ± 10.1 vs. 62.73 ± 11.1, p = 0.002) was
significant higher in CIA rats during the first three weeks.
On the other hand, HF (1st week: 30.34 ± 5.6 vs. 38.01 ±
9.1, p = 0.02 and 2nd week: 31.46 ± 5.0 vs. 39.85 ± 7.2,
p = 0.03) was significant higher in control group dur-
ing the first two weeks. In the same way, LF/HF (1st
week: 2.41 ± 0.7 vs. 1.76 ± 0.6, p = 0.01 and 2nd week:
2.24 ± 0.5 vs. 1.58 ± 0.5, p = 0.02) of CIA rats was sig-
nificant higher than control group. During 4th to
6thweek, when arthritis was relieved gradually in CIA rats,
the frequency-domain parameters had no significant dif-
ference compared with control group (Fig. 2). In the DFA
parameters, DFAα1 (1st week: 0.88 ± 0.2 vs. 0.62 ± 0.2,
p = 0.001; 2nd week: 0.82 ± 0.2 vs. 0.74 ± 0.3, p = 0.02)
and DFAα2 (1st week: 1.12 ± 0.1 vs. 0.71 ± 0.4, p = 0.002;
2nd week: 1.24 ± 0.1 vs. 1.09 ± 0.3, p = 0.03) of CIA rats
were significant higher in the first two weeks. Similarly,
there was no further change in the following weeks. With
respect to non-linear parameters, we observed lower DC
(1st week: 9.5 ± 2.4 vs. 13.7 ± 2.7, p = 0.03; 2nd week: 9.8 ±
2.6 vs. 11.1 ± 3.8, p = 0.03; 3rd week : 7.5 ± 2.8 vs. 7.6 ± 0.7,
p = 0.51; 4th week: 6.9 ± 1.1 vs. 9.6 ± 2.9, p = 0.02; 5th week:
8.2 ± 1.4 vs. 6.9 ± 1.6, p = 0.02 and 6th week: 7.3 ± 2.2 vs.
8.5 ± 3.5, p = 0.03) in CIA rats compared with control
group and there was progressive decline of DC values dur-
ing whole follow up period (Fig. 3, upper panel). Among
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Fig. 1 Macroscopic observation of joint swelling in collagen-induced arthritis (CIA) rats. a Normal rats. b Induced arthritis on day 20 of CIA rats. c
The severity of arthritis in clinical scoring. d The severity of arthritis in paw thickness. Differences between the control group and the model group
were statistically significant (p < 0.05)
Table 1 Comparison of HRV parameter between CIA rats and controls 1st week to 6th week




Control 386 ± 25 411 ± 57 411 ± 6 377 ± 21 375 ± 18 378 ± 25
CIA 458 ± 35* 438 ± 31* 471 ± 31* 493 ± 4* 383 ± 21 380 ± 28
SDNN(ms) Control 4.53 ± 2.5 6.08 ± 3.4 3.9 ± 0.9 3.55 ± 1.3 3.89 ± 1.4 3.21 ± 1.3
CIA 8.23 ± 1.6* 12.28 ± 4.3* 5.82 ± 2.7* 4.31 ± 1.0 5.26 ± 3.4 3.21 ± 1.3
RMSSD(ms) Control 3.03 ± 0.8 3.35 ± 1.4 2.37 ± 0.2 2.72 ± 0.5 2.81 ± 0.5 2.62 ± 0.5
CIA 3.37 ± 0.7 3.13 ± 0.5 2.73 ± 0.6 2.4 ± 0.1 2.44 ± 0.2 2.41 ± 0.1
LF(n.u) Control 61.71 ± 9.3 60.02 ± 7.2 62.73 ± 11.1 60.29 ± 8.5 61.59 ± 7.9 59.01 ± 9.3
CIA 69.48 ± 5.7* 68.41 ± 5.1* 68.78 ± 10.1* 57.89 ± 12.7 52.13 ± 16.1 49.73 ± 16.3
HF(n.u) Control 38.01 ± 9.1 39.85 ± 7.2 37.13 ± 11 39.38 ± 8.4 38.11 ± 7.9 40.66 ± 9.1
CIA 30.34 ± 5.6* 31.46 ± 5.0* 40.93 ± 10.1 41.77 ± 12.6 47.46 ± 15.9 49.94 ± 16.2
LF/HF Control 1.76 ± 0.6 1.58 ± 0.5 1.9 ± 0.9 1.65 ± 0.6 1.73 ± 0.6 1.56 ± 0.6
CIA 2.41 ± 0.7* 2.24 ± 0.5* 1.68 ± 0.4 1.60 ± 0.8 1.31 ± 0.7 1.2 ± 0.8
Non-linear HRV parameters
DFA:α1 Control 0.62 ± 0.2 0.74 ± 0.3 0.69 ± 0.1 0.47 ± 0.1 0.49 ± 0.1 0.51 ± 0.1
CIA 0.88 ± 0.2* 0.82 ± 0.2* 0.7 ± 0.3 0.43 ± 0.1 0.53 ± 0.1 0.52 ± 0.1
DFA:α2 Control 0.71 ± 0.4 1.09 ± 0.3 0.84 ± 0.1 0.79 ± 0.3 0.65 ± 0.2 0.52 ± 0.3
CIA 1.12 ± 0.1+ 1.24 ± 0.1* 0.81 ± 0.1 0.78 ± 0.1 0.62 ± 0.3 0.51 ± 0.3
DC(ms) Control 13.7 ± 2.7 11.1 ± 3.8 9.2 ± 0.7 9.6 ± 2.9 8.2 ± 1.4 8.5 ± 3.5
CIA 9.5 ± 2.4* 9.8 ± 2.6* 7.5 ± 2.8* 6.9 ± 1.1* 6.9 ± 1.6* 7.3 ± 2.2*
AC(ms) Control –10.6 ± 2.4 –8.1 ± 6.3 –5.2 ± 0.4 –7.3 ± 2.7 –6.1 ± 1.4 –6.3 ± 3.1
CIA –7.1 ± 2.6* –7.7 ± 2.0 –4.1 ± 3.1 –4.8 ± 0.9* –5.7 ± 1.7 –5.2 ± 1.8
*p < 0.05 when compared with control group using independent-samples t test
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AC parameters, there was opposite trend with higher
values in CIA rats (1st week: -7.1 ± 2.6 vs. -10.6 ± 2.4,
p = 0.02; 2nd week: -7.7 ± 2.0 vs. -8.1 ± 6.3, p = 0.13;
3rdweek : -4.1 ± 3.1 vs. -5.2 ± 0.4, p = 0.42; 4th week: -4.8 ±
0.9 vs. -7.3 ± 2.7, p = 0.03; 5th week: -5.7 ± 1.7 vs. -6.1
± 1.4, p = 0.04 and 6th week: -5.2 ± 1.8 vs. 6.3 ± 3.1, p =
0.33) than control (Fig. 3, lower panel)
Discussions
In this study, we examined various HRV parameters in a
CIA rat model, which mimicking the joint inflammation
of rheumatoid arthritis. We demonstrated higher time-
domain parameters, LF and LF/HF ratio during acute
arthritis stage (1st to 3rd week). There was no further dif-
ference in linear HRV parameters when the arthritis was
relieved among 4th to 6th week. On the other hand, we
observed progressive incapability of slowing and speed-
ing heart rate in CIA rats, even after relief of joints in-
flammation. This is the first study to elucidate the
temporal change of linear and non-linear HRV parame-
ters in CIA rats and indicate that DC and AC could be
potential surrogates of autonomic system dysregulation
in patients with rheumatoid arthritis.
CIA is an induced model of rheumatoid arthritis that
bears several similarities to human disease, including female
vulnerability, symmetrical synovitis and inflammatory-me-
diated damage to the cartilage and bone of joints [18,
19]. In human RA, autonomic dysfunction were fre-
quently observed and associated with an increased
mortality risk, [7, 20] characterized by reduced HRV,
Fig. 2 Heart rate variability of LF/HF of CIA rats and control group. Asterisk indicated p < 0.05 when compared with control group
Fig. 3 Deceleration and acceleration capacity of CIA rats and control group. The linear regression wasperformed by the least squares method. From
the linear regression, the R2 value, the slopes and the y-intercepts are derived. Asterisk indicated p < 0.05 when compared with control group
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an expression of sympathetic over-activity and para-
sympathetic withdraw [9, 21–23]. Most of these
cross-sectional studies found reduced time and fre-
quency domain HRV parameters in RA patients when
compared with control [24]. Because patients with
rheumatoid arthritis had long-term disease course and
several times of remission and relapsing, it was un-
likely to record the temporal change of autonomic
system. On the other hand, studies evaluating HRV in
RA animal models are very rare. Utilizing continuous
ECG recording in CIA rats and HRV analyses, our
study observed the high sympathetic outflow in the
acute stage of arthritis and ongoing damage of cardiac
autonomic function despite of remission of arthritis.
Inflammatory cytokines and local heat and pain causes
sympathetic activation by targeting the autonomic cen-
ters of the brain, consequently dampening further cyto-
kine production and immune-inflammatory activation
[25, 26]. The so-called inflammatory reflex is a self-
controlling loop and an adaptive response to inflamma-
tion. However, sympathetic over-activation also affect
the heart, possibly favoring onset of cardiac arrhythmia
[27]. In our study, during the first three weeks after the
induction, we observed increased heart rates, indicating
cardiac sympathetic activation due to arthritis. There
was higher SDNN in CIA rats, reflecting larger heart
rate fluctuation [13, 28]. Furthermore, higher LF and LF/
HF ratio in CIA rats may also represent activation of
sympathetic tone. These results were opposite to most
clinical trials evaluating HRV in RA patients, which re-
vealed reduced HRV parameters. It may be because RA
patients in most clinical trials had arthritis many times
with chronic disease course. However, arthritis was firstly
induced in our rats. In the following 4th to 6th week, when
arthritis was relieved, the time and frequency domain pa-
rameters of CIA rats declined gradually, indicating return-
ing to baseline sympathovagal activity.
Detrended fluctuation analysis method measures the
qualitative characteristics and correlation features of heart
rate behavior. Heart rate time series are fractal because
they display self-similar (scale-invariant) fluctuations over
a wide range of time scales [29]. These fluctuations are de-
termined by a delicate interplay between sympathetic and
vagal outflow [30]. The significant increased DFAα1 and
DFAα2 in our CIA rats during first two weeks reflected in-
creased sympathetic activity accompanied with withdraw
of vagal activity [30]. Likewise, after gradual relief of in-
flammation in joints, both parameters had no difference
compared with the control group.
As previously noted in method section, we used PRSA
technique to calculate DC and AC, meaning the capability
of slowing and speeding heart rates. Autonomic heart-rate
modulation due to specific regulation, such as sympathova-
gal activity, respiratory, baroreflex mediated and circadian,
occur on different timescale. PRSA technique could
synchronize all periodic components of the signal irre-
spective of their frequency and timescale. It thus integrated
all contributions of above mentioned mechanisms by accu-
mulation the amplitude at the center of PRSA signal.
Briefly, DC indicates the overall deceleration capacity of
sinus rhythm, without being linked necessarily to one par-
ticular physiological process [31]. In our study, we found
the progressive decline of DC despite of the recovery of
arthritis. One possible explanation was that other patho-
physiologic mechanisms persistently affected the SA node
function in CIA rats regardless of diminished impact of in-
flammation reflex or sympathetic activity indicated by
HRV. Noteworthy, by using short-duration ECG recording
rather than long-term recording, the DC measurement
would not have to account for various level of activity of
CIA rats [32]. There was similar trend of progressive in-
crease of AC but not achieving significant difference. On
the other hand, our findings support that DC might be a
more sensitive parameter than HRV and DFA in revealing
a residual activation of the inflammatory process [31]. The
residual elevated mean clinical score and paw thickness
were still noted 6 weeks after the induction (Fig. 1, panels c
and d, day 42), suggesting the persistence to a certain de-
gree of inflammatory activation.
Previous studies suggested inflammatory cytokines,
particularly TNF-α, could promote cardiac sympathetic
activation and arrhythmic events and treatment with
TNF-α antagonist could alleviate sympatho-vagal imbal-
ance [33, 34]. HRV impairment was significantly associated
with disease duration, activity and inflammation markers
[35, 36]. However, few study evaluated the association of
HRV impairment and cardiovascular outcomes in RA
population [37], although growing evidences indicate in-
creased cardiovascular mortality [38, 39]. In addition to
conventional risk predictors of HRV proposed by the
guideline [13], DC is a good predictor of morality of survi-
vors after myocardial infarction [31]. We also demon-
strated that DC is a sensitive markers of cardiac autonomic
dysfunction in CIA rats.
Limitation
There were some limitations of this study. Firstly, our rats
were not monitored everyday, leaving some data gaps al-
though our study investigated the temporal change of
HRV in CIA rats. Secondly, the conclusions derived from
the relatively small numbers of control and CIA rats may
require careful consideration of the assumption. Thirdly,
the severity of arthritis was based on clinical score
measurement, lacking histopathology of joints and in-
flammatory cytokines from CIA rats. Similarly, we
evaluate the activity of sympathetic system by using
conventional HRV parameters, lacking baroreflex sen-
sitivity or skeletal muscle sympathetic nerve activity.
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Conclusions
Our study demonstrated for the first time the dynamic
change of sympathetic activity by using HRV analyses.
After relief of arthritis and decline of sympathetic activity,
the damage to cardiac autonomic function persisted which
reflected by the reduced DC. Using these observations,
more in-depth studies could be carried on to evaluate the
association of autonomic dysfunction and cardiovascular
events in human RA population.
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